ScreenerHero

TECH Bio-Techne Corporation

NAS · US · Healthcare · Biotechnology · bio-techne.com
72.58USD+0.25%Mkt Cap: 11.38B $P/E: 62.57

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates t…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap11.38B USD
Enterprise Value11.38B USD
Revenue (TTM)1.22B USD
Gross Profit799.07M USD
Net Income (TTM)181.86M USD
Revenue/Share7.79 USD
Last Price72.58 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)62.57
P/E (Forward)31.31
PEG2.11
EV/EBITDA34.05
EV/Revenue9.36
P/S9.34
P/B5.36
EPS (TTM)1.16
EPS (Forward)2.31
52W Range
43.20100% of range72.69
52W High72.69 USD
52W Low43.20 USD
Profitability
Gross Margin65.77%
Oper. Margin27.87%
EBITDA Margin27.50%
Profit Margin14.97%
ROE8.63%
ROA7.03%
Growth
Revenue Growth1.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF292.07M USD
CapEx (TTM)28.85M USD
FCF Margin18.90%
FCF Yield2.02%
Net Debt23.61M USD
Net Debt/EBITDA0.07
Balance Sheet
Debt/Equity0.14
Current Ratio4.55
Quick Ratio2.94
Book Value/Sh13.51 USD
Cash/Share1.69 USD
Dividends
Fwd Div Rate0.32 USD
Trail. Div Rate0.32 USD
Div. Yield0.44%
5Y Avg Yield0.43%
Payout Ratio27.59%
Ex-Div DateAug 24, 2026
Pay DateSep 4, 2026
Splits
Last Split4:1
Split DateNov 30, 2022
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)70.50 USD
Upside (mean)-2.9%
Target Range50.00 USD – 73.00 USD
50.00-2.9% to mean73.00
# Analysts10
Ownership
Shares Out.156.82M
Float156.15M
Insiders0.34%
Institutions114.80%
Short Interest
Short Ratio2.7d
Short % Float4.24%
Short % Out.4.23%
Shares Short6.63M
Short (prev mo.)6.46M
Technical
SMA 5072.27 (+0.4%)
SMA 20062.04 (+17.0%)
Beta1.27
S&P 52W Chg14.58%
Avg Vol (30d)2.63M
Avg Vol (10d)3.17M
Technical Indicators
RSI (14)63.5
MACD0.2438
MACD Signal0.3242
MACD Hist.-0.0803
BB Upper72.69 USD
BB Middle72.40 USD
BB Lower72.10 USD
BB Width0.81%
ATR (14)0.2262 USD
Vol Ratio (20d)0.73x